Residual subjective daytime sleepiness under CPAP treatment in initially somnolent apnea patients: a pilot study using data mining methods.

BACKGROUND AND PURPOSE Despite correct treatment with positive airway pressure (PAP), obstructive sleep apnea (OSA) patients sometimes remain subjectively somnolent. The reliability of the Epworth Sleepiness Scale (ESS) has been established for healthy subjects and patients under stable conditions; the ESS may eventually vary among treated OSA patients, biasing the results of a cross-sectional analysis of persisting sleepiness. The objective of this study was to depict the evolution of subjective vigilance under treatment using an index of ESS variability (DeltaESS). METHODS In 80 OSA patients (apnea-hypopnea index [AHI]=54+/-26/h), initially somnolent (ESS=15+/-3) and treated with auto-titrating PAP (APAP) (oxyhaemoglobin desaturation index 3% [ODIapap]=3.4+/-2.2/h; daily APAP use=5.3+/-1.5 h) during 434+/-73 days, ESS scores were regularly collected four times every 109+/-36 days. DESS was calculated and data mining methods (Segmentation and Decision Tree) were used to determine homogeneous groups according to the evolution of ESS scores. RESULTS When assessed cross-sectionally, 14-25% of the subjects were recognized as somnolent, depending on the moment when ESS was administered. Using data mining methods, three groups were clearly identifiable: two without residual somnolence - group 1, n=38 (47%), with high DeltaESS=-2.9+/-0.8, baseline ESS=16.3+/-3.3, AHI=58.5+/-26.1/h, mean ESSapap=5.1+/-2.4 and group 2, n=31 (39%), with low DeltaESS=-1.1+/-0.5, baseline ESS=13.2+/-1.4, AHI=53+/-27.3/h, mean ESSapap=8.8+/-1.9; and one with persisting sleepiness; group 3, n=11 (14%), with low DeltaESS=-0.3+/-0.8, baseline ESS=16.3+/-3, AHI=38.7+/-10.8/h, mean ESSapap=14.1+/-1.9. Compliance to PAP was high and comparable in the three groups. Age and body mass index (BMI) did not differ. CONCLUSION Data mining methods helped to identify 14% of subjects with persisting sleepiness. Validation needs to be done on a larger population in order to determine predictive rules.

[1]  C. Hukins.  Comparative study of autotitrating and fixed-pressure CPAP in the home: a randomized, single-blind crossover trial. , 2004, Sleep.

[2]  R. Chervin.  Epworth sleepiness scale? , 2003, Sleep medicine.

[3]  N J Douglas,et al.  Randomized, double-blind, placebo-controlled crossover trial of modafinil in the treatment of residual excessive daytime sleepiness in the sleep apnea/hypopnea syndrome. , 2001, American journal of respiratory and critical care medicine.

[4]  Crispin Jenkinson,et al.  Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised parallel trial , 2002, The Lancet.

[5]  R. Berry,et al.  The use of auto-titrating continuous positive airway pressure for treatment of adult obstructive sleep apnea. An American Academy of Sleep Medicine review. , 2002, Sleep.

[6]  T. Young,et al.  Predictors of objective sleep tendency in the general population. , 2003, Sleep.

[7]  C. George.  Reduction in motor vehicle collisions following treatment of sleep apnoea with nasal CPAP , 2001, Thorax.

[8]  N. Douglas,et al.  Long-term use of CPAP therapy for sleep apnea/hypopnea syndrome. , 1999, American journal of respiratory and critical care medicine.

[9]  J. Stradling,et al.  Comparison of three ways to determine and deliver pressure during nasal CPAP therapy for obstructive sleep apnoea , 2005, Thorax.

[10]  M. Johns,et al.  A new method for measuring daytime sleepiness: the Epworth sleepiness scale. , 1991, Sleep.

[11]  Greg Maislin,et al.  Relationship between hours of CPAP use and achieving normal levels of sleepiness and daily functioning. , 2007, Sleep.

[12]  M. Johns,et al.  Reliability and factor analysis of the Epworth Sleepiness Scale. , 1992, Sleep.

[13]  J. Stradling,et al.  Sleep ? 1: Obstructive sleep apnoea/hypopnoea syndrome: definitions, epidemiology, and natural history , 2003 .

[14]  W. Flemons,et al.  Clinical usefulness of home oximetry compared with polysomnography for assessment of sleep apnea. , 2005, American journal of respiratory and critical care medicine.

[15]  N. Ayas,et al.  Diagnosis and Initial Management of Obstructive Sleep Apnea without Polysomnography , 2007, Annals of Internal Medicine.

[16]  N. Collop,et al.  The upper airway resistance syndrome. , 1999, Chest.

[17]  Ian H. Witten,et al.  Data mining: practical machine learning tools and techniques with Java implementations , 2002, SGMD.

[18]  C Guilleminault,et al.  A cause of excessive daytime sleepiness. The upper airway resistance syndrome. , 1993, Chest.

[19]  N. Douglas,et al.  Clinical value of polysomnography , 1992, The Lancet.

[20]  C. Brambilla,et al.  Accuracy of oximetry for detection of respiratory disturbances in sleep apnea syndrome. , 1996, Chest.

[21]  D. Hudgel,et al.  A long-term randomized, cross-over comparison of auto-titrating and standard nasal continuous airway pressure. , 2000, Sleep.

[22]  M. Hirshkowitz,et al.  Modafinil as adjunct therapy for daytime sleepiness in obstructive sleep apnea: a 12-week, open-label study. , 2003, Chest.

[23]  B. Phillips.  Alternative Methods of Titrating Continuous Positive Airway Pressure: A Large Multicenter Study , 2006 .

[24]  D. Kristo,et al.  Overnight pulse oximetry for sleep-disordered breathing in adults: a review. , 2001, Chest.

[25]  M. Littner,et al.  Practice parameters for clinical use of the multiple sleep latency test and the maintenance of wakefulness test. , 2005, Sleep.

[26]  Ian H. Witten,et al.  Data mining: practical machine learning tools and techniques, 3rd Edition , 1999 .

[27]  N. Douglas,et al.  Treatment with Continuous Positive Airway Pressure Is Not Effective in Patients with Sleep Apnea but No Daytime Sleepiness , 2001, Annals of Internal Medicine.

[28]  T. Roth,et al.  Recovery of alertness after CPAP in apnea. , 1989, Chest.

[29]  J. Terán-Santos,et al.  The association between sleep apnea and the risk of traffic accidents. Cooperative Group Burgos-Santander. , 1999, The New England journal of medicine.

[30]  D. Hudgel,et al.  Comparison between automatic and fixed positive airway pressure therapy in the home. , 2003, American journal of respiratory and critical care medicine.

[31]  W. Flemons,et al.  Access to diagnosis and treatment of patients with suspected sleep apnea. , 2004, American journal of respiratory and critical care medicine.

[32]  M. Littner,et al.  Practice parameters for the use of auto-titrating continuous positive airway pressure devices for titrating pressures and treating adult patients with obstructive sleep apnea syndrome. An American Academy of Sleep Medicine report. , 2002, Sleep.

[33]  Cathy Alessi,et al.  Practice parameters for the use of autotitrating continuous positive airway pressure devices for titrating pressures and treating adult patients with obstructive sleep apnea syndrome: an update for 2007. An American Academy of Sleep Medicine report. , 2008, Sleep.

[34]  I. Deary,et al.  Effect of continuous positive airway pressure treatment on daytime function in sleep apnoea/hypopnoea syndrome , 1994, The Lancet.

[35]  N. Douglas,et al.  "Why am I sleepy?": sorting the somnolent. , 2001, American journal of respiratory and critical care medicine.

[36]  D. Gottlieb,et al.  Sleepiness in patients with moderate to severe sleep-disordered breathing. , 2005, Sleep.

[37]  A. Malhotra,et al.  Continuous positive airway pressure therapy for treating sleepiness in a diverse population with obstructive sleep apnea: results of a meta-analysis. , 2003 .

[38]  P. Hauri,et al.  An American Academy of Sleep Medicine Review , 2000 .